2m 2m 2m 2m 2m 2m 2m
TELA BIO (TELA)
NASDAQ
$0.87+$0.009 (+1.05%)
Price as of Jun 03, 2026 6:49 PM EDT- $43.4MMarket Cap
- -42.04%1-Year Change
- Medical DevicesIndustry
TELA BIO (TELA)
$0.87+$0.009 (+1.05%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 80.3M +15.84% | 69.3M +18.56% | 58.5M +41.13% | 41.4M +40.58% | |
Cost of Revenue | 25.6M +13.92% | 22.4M +24.89% | 18.0M +32.36% | 13.6M +31.16% | |
Gross Profit | 54.3M +16.89% | 46.5M +15.90% | 40.1M +48.32% | 27.0M +43.75% | |
Sales and Marketing Expense | 63.2M -2.27% | 64.6M +8.32% | 59.7M +37.98% | 43.3M +48.83% | |
Research and Development Expense | -9.2M +4.62% | -8.8M -8.38% | -9.6M +7.63% | -8.9M +32.54% | |
Depreciation and Amortization Expense | 630,000 -0.32% | 632,000 +47.66% | 428,000 +11.75% | 383,000 +65.80% | |
Total Operating Expenses | 88.1M -0.10% | 88.2M +4.75% | 84.2M +27.46% | 66.1M +36.85% | |
Operating Profit | -33.8M -1.06% | -34.1M -22.60% | -44.1M +12.99% | -39.0M +32.45% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -1.1M -79.25% | -5.3M +1.47% | -5.2M +28.93% | -4.1M +12.62% | |
Interest Income and Expense and Net | -1.1M -79.25% | -5.3M +1.47% | -5.2M +28.93% | -4.1M +12.62% | |
Total Nonoperating Income and Expense | -4.8M +25.22% | -3.9M +49.48% | -2.6M -51.05% | -5.3M +38.27% | |
Income before Taxes | -38.6M +1.62% | -38.0M -13.82% | -44.1M +12.99% | -39.0M +17.22% | |
Income Taxes | 230,000 +259.72% | -144,000 N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -38.8M +2.62% | -37.8M -18.91% | -46.7M +5.35% | -44.3M +33.12% | |
Net Income from Continuing Operations Applicable to Common | -38.6M +1.62% | -38.0M -18.60% | -46.7M +5.35% | -44.3M +33.12% | |
Basic EPS and Net Income | -0.83 -37.59% | -1.33 -34.80% | -2.04 -25.00% | -2.72 +18.26% | |
Diluted EPS and Net Income | -0.83 -37.59% | -1.33 -34.80% | -2.04 -25.00% | -2.72 +18.26% | |
Basic Weighted Average Shares | 46.9M +64.58% | 28.5M +24.74% | 22.9M +40.58% | 16.3M +12.40% | |
Diluted Weighted Average Shares | 46.9M +64.58% | 28.5M +24.74% | 22.9M +40.58% | 16.3M +12.40% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 50.8M -3.46% | 52.7M +12.71% | 46.7M +11.21% | 42.0M -4.35% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 50.8M -3.46% | 52.7M +12.71% | 46.7M +11.21% | 42.0M -4.35% | |
Total Current Assets | 75.6M -3.19% | 78.1M +8.85% | 71.7M +14.86% | 62.4M +5.74% | |
Accumulated Depreciation | 3.5M -25.15% | 4.7M +7.50% | 4.3M +4.71% | 4.1M +10.19% | |
Property and Plant and Equipment and Net | 2.2M -4.91% | 2.3M +17.99% | 2.0M +17.95% | 1.7M +41.82% | |
Total Long-Term Assets | 500,000 -78.03% | 2.3M +14.72% | 2.0M +17.95% | 1.7M +41.82% | |
Total Assets | 81.4M -5.95% | 86.6M +10.92% | 78.0M +15.02% | 67.9M +8.49% | |
Income Taxes Payable | 725,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 18.0M +15.24% | 15.6M -8.07% | 17.0M +36.80% | 12.4M +17.29% | |
Total Long-Term Debt | 55.7M +35.33% | 41.1M +1.50% | 40.5M -43.26% | 71.4M +126.75% | |
Total Long-Term Liabilities | 1.5M +6.26% | 1.4M -17.51% | 1.7M +36.88% | 1.2M +223.95% | |
Total Liabilities | 75.1M +29.24% | 58.1M -1.78% | 59.2M +10.49% | 53.5M +26.16% | |
Retained Earnings | -397.6M +10.82% | -358.7M +11.79% | -320.9M +17.02% | -274.2M +19.27% | |
Total Stockholders Equity | 6.3M -77.82% | 28.5M +50.72% | 18.9M +31.99% | 14.3M -28.82% | |
Total Shares Outstanding | 44.5M +13.05% | 39.4M +60.83% | 24.5M +27.81% | 19.2M +31.90% | |
Cash Flow | |||||
Cash from Operating Activities | -28.2M -32.16% | -41.6M +1.81% | -40.9M +0.27% | -40.7M +33.90% | |
Capital Expenditures | 448,000 -54.70% | 989,000 +61.87% | 611,000 -29.93% | 872,000 +39.07% | |
Cash from Investing Activities | 846,000 -80.99% | 4.5M +843.07% | -599,000 -68.00% | -1.9M +198.56% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 25.8M -40.20% | 43.1M -6.94% | 46.3M +13.26% | 40.9M +6,883.25% | |
Financials Ratio | |||||
Gross Margin | 68.17% +0.79% | 67.63% -2.37% | 69.27% +3.03% | 67.24% +3.62% | |
Operating Margin | -42.05% -14.58% | -49.23% -34.71% | -75.40% -19.94% | -94.18% -5.78% | |
Return on Assets | -46.23% +0.56% | -45.97% -28.13% | -63.97% -5.85% | -67.94% +52.11% | |
Return on Equity | -223.35% +39.71% | -159.87% -43.15% | -281.23% +9.21% | -257.51% +167.46% | |
Revenue Growth | 15.84% -14.66% | 18.56% -54.88% | 41.13% +1.36% | 40.58% -34.31% | |
Current Ratio | 4.20 -15.99% | 5.01 +18.40% | 4.23 -16.04% | 5.03 -9.84% | |
Cash Ratio | 2.83 -16.23% | 3.38 +22.61% | 2.75 -18.71% | 3.39 -18.45% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow